Anti-MS4A5/ CD20-L2/ CD20L2 monoclonal antibody

Anti-MS4A5/ CD20-L2/ CD20L2 antibody for FACS & in-vivo assay

Target products collectionGo to MS4A5/MS4A5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0846-Ab-1/ GM-Tg-hg-MP0846-Ab-2Anti-Human MS4A5 monoclonal antibodyHuman
GM-Tg-rg-MP0846-Ab-1/ GM-Tg-rg-MP0846-Ab-2Anti-Rat MS4A5 monoclonal antibodyRat
GM-Tg-mg-MP0846-Ab-1/ GM-Tg-mg-MP0846-Ab-2Anti-Mouse MS4A5 monoclonal antibodyMouse
GM-Tg-cynog-MP0846-Ab-1/ GM-Tg-cynog-MP0846-Ab-2Anti-Cynomolgus/ Rhesus macaque MS4A5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0846-Ab-1/ GM-Tg-felg-MP0846-Ab-2Anti-Feline MS4A5 monoclonal antibodyFeline
GM-Tg-cang-MP0846-Ab-1/ GM-Tg-cang-MP0846-Ab-2Anti-Canine MS4A5 monoclonal antibodyCanine
GM-Tg-bovg-MP0846-Ab-1/ GM-Tg-bovg-MP0846-Ab-2Anti-Bovine MS4A5 monoclonal antibodyBovine
GM-Tg-equg-MP0846-Ab-1/ GM-Tg-equg-MP0846-Ab-2Anti-Equine MS4A5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0846-Ab-1/ GM-Tg-hg-MP0846-Ab-2; GM-Tg-rg-MP0846-Ab-1/ GM-Tg-rg-MP0846-Ab-2;
GM-Tg-mg-MP0846-Ab-1/ GM-Tg-mg-MP0846-Ab-2; GM-Tg-cynog-MP0846-Ab-1/ GM-Tg-cynog-MP0846-Ab-2;
GM-Tg-felg-MP0846-Ab-1/ GM-Tg-felg-MP0846-Ab-2; GM-Tg-cang-MP0846-Ab-1/ GM-Tg-cang-MP0846-Ab-2;
GM-Tg-bovg-MP0846-Ab-1/ GM-Tg-bovg-MP0846-Ab-2; GM-Tg-equg-MP0846-Ab-1/ GM-Tg-equg-MP0846-Ab-2
Products NameAnti-MS4A5 monoclonal antibody
Formatmab
Target NameMS4A5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MS4A5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MS4A5/ CD20-L2/ CD20L2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0846
    Target NameMS4A5
    Gene ID64232,269063,612568,101101413,777599,100061545
    Gene Symbol and SynonymsCD20-L2,CD20L2,MS4A5,TE™4
    Uniprot AccessionQ9H3V2
    Uniprot Entry NameMS4A5_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166930
    Target ClassificationN/A

    The target: MS4A5, gene name: MS4A5, also named as CD20-L2, CD20L2, TE™4. This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. Though this member is not expressed in hematopoietic cells specifically, it may be involved in signal transduction like many of its related family members. The gene encoding this protein is localized to 11q12, among a cluster of family members. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.